SCHEMBL1770271

SCHEMBL1770271

Cc1cccc(S(=O)(=O)CC(=O)C23CC4CC(CC(C4)C2)C3)n1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.52
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
TP53 P04637 1/20 0.43
ATM Q13315 1/20 0.43
HPGD P15428 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.40
GBA1 P04062 1/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
PTGES O14684 1/20 0.39
CNR2 P34972 1/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1770013 0.80 HSD11B1 (0.50) HSD11B1MEN1KMT2AALDH1A1KDM4E
SCHEMBL3321222 0.74 HSD11B1 (0.53) HSD11B1KMT2AALDH1A1HPGDNPSR1
SCHEMBL1770092 0.73 HSD11B1 (0.52) HSD11B1MEN1KMT2AALDH1A1KDM4E
SCHEMBL1770030 0.73 PTGES (0.52) HSD11B1MEN1KMT2AALDH1A1KDM4E
SCHEMBL13333321 0.73 ALDH1A1 (0.48) HSD11B1MEN1KMT2AALDH1A1KDM4E
SCHEMBL1770354 0.71 MEN1 (0.42) HSD11B1MEN1KMT2AALDH1A1KDM4E
SCHEMBL3323054 0.71 HSD11B1 (0.56) HSD11B1MEN1KMT2AALDH1A1KDM4E
SCHEMBL1770009 0.71 PPARD (0.45) HSD11B1
SCHEMBL3323351 0.70 NPC1 (0.51) HSD11B1KMT2AALDH1A1KDM4EHPGD
SCHEMBL12780478 0.70 CCR1 (0.43) HSD11B1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 US disclosed
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 US disclosed
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 US disclosed
EP-2257528-A2 1 IBETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2010-12-08 EP disclosed
WO-2009106817-A2 COMPOUND STERIX LIMITED (GB) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885MEN1 2644/4885KMT2A 2328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.